MicroRNA Market to Grow with a CAGR of 12.19% through 2028

Rising prevalence of chronic diseases is expected to drive the Global MicroRNA Market growth in the forecast period, 2024-2028. 

According to TechSci Research report, “MicroRNA Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global MicroRNA Market stood at USD 1548.17 Million in 2022 and is anticipated to grow with a CAGR of 12.19% in the forecast period, 2024-2028. A primary driver behind the growth of the Global MicroRNA Market is the escalating prevalence of chronic diseases worldwide. MiRNAs have demonstrated immense potential as biomarkers for diseases such as cancer, cardiovascular disorders, and neurological conditions. Their ability to reflect the molecular intricacies of these diseases has positioned them as invaluable tools for early diagnosis, prognosis, and personalized treatment plans.

The landscape of miRNA research has been transformed by remarkable advancements in sequencing and profiling technologies. High-throughput sequencing techniques have allowed researchers to identify and profile miRNAs with unprecedented speed and accuracy. This has not only facilitated comprehensive studies on miRNA expression patterns but has also enabled the development of more targeted diagnostic tools and therapeutic interventions.

MicroRNAs have become integral components of diagnostic strategies, playing a crucial role in the era of personalized medicine. The ability of miRNAs to provide insights into the underlying molecular mechanisms of diseases has led to their incorporation into diagnostic assays for various conditions. Their presence as biomarkers in liquid biopsies has opened new avenues for non-invasive diagnostic approaches, revolutionizing the way diseases are detected and monitored.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global MicroRNA Market”

The Global MicroRNA Market is segmented into Products & Services, End-Use, Application, Regional Distribution, And Company.

Based on the Products & Services, services emerged as the dominant segment in the global market for Global MicroRNA in 2022. Research and development initiatives focusing on microRNA-based applications, such as biomarker discovery and therapeutic interventions, have intensified, fostering a robust market for specialized services. The comprehensive support provided by service providers in navigating the challenges associated with miRNA research, including sample processing, data interpretation, and assay optimization, has positioned services as an integral component of the Global MicroRNA Market. This trend reflects the industry's recognition of the value-added by expert services in advancing the understanding and application of microRNAs in diverse biomedical fields.

Based on the End-Use, academic & government research institutes emerged as the dominant segment in the global market for Global MicroRNA Market  in 2022. The dominance of this segment is fueled by the relentless pursuit of knowledge in miRNA research, with a focus on biomarker discovery, disease profiling, and exploring therapeutic applications. These institutions act as hubs for innovation, fostering collaborations, and driving advancements in sequencing technologies, bioinformatics, and experimental methodologies related to miRNA studies. Additionally, government funding and grants often support miRNA research initiatives within these institutions, providing the necessary resources for comprehensive investigations. The academic and government research institutes' dominance underscores their crucial role in laying the foundation for the broader applications of miRNAs in diagnostics and therapeutics. As they continue to spearhead pioneering studies, the Global MicroRNA Market is poised to benefit from the insights and discoveries emerging from these academic and government research hubs.

Based on the Application, cancer segment emerged as the dominant segment in the global market for Global MicroRNA Market in 2022. This is due to the recognition of miRNAs as crucial players in cancer biology, influencing key processes such as cell proliferation, apoptosis, and metastasis. The unique miRNA signatures associated with different cancer types make them valuable biomarkers for early detection, prognosis, and monitoring treatment responses. Researchers and clinicians are increasingly leveraging miRNAs to unravel the complexities of cancer biology, identifying specific miRNA profiles indicative of different stages and subtypes of cancer. The potential of miRNAs as diagnostic tools extends to liquid biopsies, where circulating miRNAs offer a non-invasive approach to cancer detection.

The North American region has been at the forefront of technological innovation in healthcare, including diabetes management. This regional dominance is attributed to a confluence of factors that contribute to the robust growth and advancement of the microRNA sector. The well-established presence of leading pharmaceutical and biotechnology companies, coupled with a sophisticated healthcare infrastructure, positions North America at the forefront of microRNA research and commercialization. The region's strong emphasis on research and development, particularly in the field of molecular diagnostics and personalized medicine, has fueled substantial investments in microRNA-related initiatives. Academic and research institutions, coupled with substantial government funding, contribute significantly to the region's expertise in unraveling the complexities of microRNA biology and its applications.

Major companies operating in MicroRNA Market are:

• Merck KGaA
• Thermo Fisher Scientific, Inc. 
• Horizon Discovery Ltd.
• Synlogic
• QIAGEN
• GeneCopoeia, Inc. 
• New England Biolabs
• Quantabio
• NanoString

Download Free Sample Report

Customers can also request  for 10% free customization on this report

 “The Global MicroRNA Market is poised for robust growth in the coming years. Anticipated advancements in sequencing technologies, particularly next-generation sequencing, will provide researchers with unprecedented insights into the intricacies of microRNA biology, fostering a deeper understanding of their roles in health and disease. The rising trend of liquid biopsies, fueled by the non-invasive nature of miRNA detection in bodily fluids, is expected to gain further traction, revolutionizing disease diagnostics and monitoring. Additionally, the continued exploration of miRNA-based therapeutics and the integration of artificial intelligence in miRNA research are poised to unlock new dimensions in precision medicine and personalized healthcare. Strategic collaborations between academia, pharmaceutical companies, and biotechnology firms are likely to catalyze innovation and accelerate the translation of microRNA discoveries into clinical applications”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Products & Services (Instruments, Consumables, Services ), By Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others), By End-Use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Other end-users) Region and Competition”, has evaluated the future growth potential of Global MicroRNA Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global MicroRNA Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]